Literature DB >> 3875400

Genetic complexity of glucocorticoid-induced lysis of murine T-lymphoma cells.

S E Weinroth, C L MacLeod, L Minning, E F Hays.   

Abstract

Several well characterized murine T-lymphoma cell lines were used in somatic cell hybridization experiments to study the genetic regulation of glucocorticoid-induced lysis. Cell fusions were carried out among the SL12-derived cloned lines and between the W7 and SAK8 lines all of which have functional hormone receptors. These cell lines differ in their sensitivity to glucocorticoid-induced lysis. The resultant hybrids were characterized by their growth response to 1 microM dexamethasone, their hormone receptor content, their chromosome number, and the expression of surface antigens. Fusion of the hormone-sensitive W7 parent to a number of glucocorticoid-resistant cell lines resulted in hybrids which were of the sensitive phenotype. In contrast the fusion of another hormone-sensitive clone, SL12.4, with glucocorticoid-resistant SL12 clones or with SAK8 always resulted in hybrids resistant to glucocorticoid lysis. These results reveal a complex genetic regulation of the hormone response or the requirement for multiple gene activity in the mechanism for glucocorticoid-induced cell lysis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3875400

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  3 in total

1.  Negative trans-regulation of T-cell antigen receptor/T3 complex mRNA expression in murine T-lymphoma somatic cell hybrids.

Authors:  C L MacLeod; L Minning; D P Gold; C Terhorst; M Wilkinson
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

2.  Apoptosis and Bcl-2 expression in cultured murine splenic T cells.

Authors:  H E Broome; C M Dargan; E F Bessent; S Krajewski; J C Reed
Journal:  Immunology       Date:  1995-03       Impact factor: 7.397

3.  The expression of several T cell-specific and novel genes is repressed by trans-acting factors in immature T lymphoma clones.

Authors:  M F Wilkinson; J Doskow; R von Borstel; A M Fong; C L MacLeod
Journal:  J Exp Med       Date:  1991-07-01       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.